![share_log](https://pubimg.futunn.com/202205090000030508c5dccc324.jpg?imageMogr2/thumbnail/76x76!/ignore-error/1/format/webp)
- 投资产品
- 交易功能
- 市场分析
- 费用和利率
- 优惠活动
- 资源
- 帮助中心
- 关于我们
- 关于moomoo
- 品牌动态
- Moomoo 桌面端
- Moomoo 基金会
- 红人计划
- 投资者关系您即将从moomoo.com跳转至富途控股官方网站。
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
- 要闻
- 市场参与者认可完美医疗健康-脑机管理有限公司(HKG:1830)的收益
Market Participants Recognise Perfect Medical Health Management Limited's (HKG:1830) Earnings
Market Participants Recognise Perfect Medical Health Management Limited's (HKG:1830) Earnings
It's not a stretch to say that Perfect Medical Health Management Limited's (HKG:1830) price-to-earnings (or "P/E") ratio of 11x right now seems quite "middle-of-the-road" compared to the market in Hong Kong, where the median P/E ratio is around 10x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/E.
While the market has experienced earnings growth lately, Perfect Medical Health Management's earnings have gone into reverse gear, which is not great. One possibility is that the P/E is moderate because investors think this poor earnings performance will turn around. You'd really hope so, otherwise you're paying a relatively elevated price for a company with this sort of growth profile.
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20241003/0-03e3cc61b7a394c8a2fa04d85ab0d23d-0-5c43ae07227c563dce05dd8cd298fddf.png/big)
How Is Perfect Medical Health Management's Growth Trending?
The only time you'd be comfortable seeing a P/E like Perfect Medical Health Management's is when the company's growth is tracking the market closely.
Taking a look back first, we see that there was hardly any earnings per share growth to speak of for the company over the past year. Likewise, not much has changed from three years ago as earnings have been stuck during that whole time. Therefore, it's fair to say that earnings growth has definitely eluded the company recently.
Looking ahead now, EPS is anticipated to climb by 12% per annum during the coming three years according to the only analyst following the company. Meanwhile, the rest of the market is forecast to expand by 12% per year, which is not materially different.
With this information, we can see why Perfect Medical Health Management is trading at a fairly similar P/E to the market. Apparently shareholders are comfortable to simply hold on while the company is keeping a low profile.
The Key Takeaway
While the price-to-earnings ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of earnings expectations.
As we suspected, our examination of Perfect Medical Health Management's analyst forecasts revealed that its market-matching earnings outlook is contributing to its current P/E. Right now shareholders are comfortable with the P/E as they are quite confident future earnings won't throw up any surprises. It's hard to see the share price moving strongly in either direction in the near future under these circumstances.
It is also worth noting that we have found 1 warning sign for Perfect Medical Health Management that you need to take into consideration.
If you're unsure about the strength of Perfect Medical Health Management's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
完美医疗脑机管理有限公司(HKG:1830)目前的市盈率(或“P/E”)比为11倍,与香港市场中位数约为10倍相比,似乎相当“普通”。然而,如果市盈率没有合理依据,投资者可能忽视了一个明显的机会或潜在的挫折。
尽管市场最近经历了盈利增长,完美医疗脑机的收益已经逆转,这并不好。一个可能性是,市盈率适中是因为投资者认为这种糟糕的盈利表现将会好转。您真的希望如此,否则您将为这种增长概况的公司支付相对较高的价格。
![大](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20241003/0-03e3cc61b7a394c8a2fa04d85ab0d23d-0-5c43ae07227c563dce05dd8cd298fddf.png/big)
完美医疗脑机管理的增长趋势如何?
惟有在公司的增长与市场紧密跟踪时,您才会舒适地看到完美医疗脑机管理这样的市盈率。
首先回顾一下,我们可以看到公司过去一年几乎没有每股收益的增长。 同样,三年前的情况也没有太大变化,收益在整个时间段内都没有增长。 因此,可以说公司最近确实没有实现收益增长。
展望未来,根据唯一跟踪该公司的分析师预测,每股收益预计在未来三年内将增长12%。 与此同时,市场的其他部分预计每年增长12%,这并没有太大的不同。
有了这些信息,我们可以看到为什么完美医疗健康管理公司的市盈率与市场相当相似。 显然,股东们很乐意继续持有股份,而公司则保持低调。
重要提示
虽然市盈率不应是您是否购买股票的决定性因素,但它是企业盈利预期的比较良好的指标。
正如我们所怀疑的那样,我们对完美医疗健康管理公司的分析师预测的检查显示,其与市场匹配的盈利前景有助于支撑其当前的市盈率。 目前,股东们对市盈率感到满意,因为他们非常确信未来的收益不会出现任何意外。 在这种情况下,很难看到股价在不久的将来出现较大波动。
值得注意的是,我们已经发现了一个关于完美医疗的警告信号,您需要考虑。
如果您对完美医疗-脑机健康管理的业务实力感到不确定,为什么不浏览我们的互动股票列表,了解一些其他可能错过的具有坚实业务基本面的公司。
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Moomoo Securities Australia Limited提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Moomoo Securities Australia Limited, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Moomoo Securities Australia Limited提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Moomoo Securities Australia Limited, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
![](https://usavatar.moomoo.com/public/profile/77777055/20230816/55054224.jpeg/120)